By shedding light on the ECE‐1/ET‐1 axis as a key molecular conduit between systemic dyslipidemia and retinal vascular pathology, we propose a new framework for understanding and potentially mitigating the ocular consequences of metabolic syndrome and related conditions. The gene discussed is EDN1; the disease is metabolic syndrome.